For: | Chen SL, Wang GP, Shi DR, Yao SH, Chen KD, Yao HP. RON in hepatobiliary and pancreatic cancers: Pathogenesis and potential therapeutic targets. World J Gastroenterol 2021; 27(20): 2507-2520 [PMID: 34092972 DOI: 10.3748/wjg.v27.i20.2507] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v27/i20/2507.htm |
Number | Citing Articles |
1 |
James C. Davis, Susan E. Waltz. The MET Family of Receptor Tyrosine Kinases Promotes a Shift to Pro-Tumor Metabolism. Genes 2024; 15(7): 953 doi: 10.3390/genes15070953
|
2 |
Baohui Qi, Fei Wang, Huan He, Mengmeng Fan, Liping Hu, Li Xiong, Guowei Gong, Shengmin Shi, Xiaomeng Song. Identification of (S)-1-(2-(2,4-difluorophenyl)-4-oxothiazolidin-3-yl)-3-(4-((7-(3-(4-ethylpiperazin-1-yl)propoxy)-6-methoxyquinolin-4-yl)oxy)-3,5-difluorophenyl)urea as a potential anti-colorectal cancer agent. European Journal of Medicinal Chemistry 2022; 239: 114561 doi: 10.1016/j.ejmech.2022.114561
|
3 |
Yuemiao Xu, Jiahan Le, Jiangjiang Qin, Yuhua Zhang, Jiaying Yang, Zhuo Chen, Changyu Li, Xiang Qian, Aiqin Zhang. Decoding the microbiota metabolome in hepatobiliary and pancreatic cancers: Pathways to precision diagnostics and targeted therapeutics. Pharmacological Research 2024; 208: 107364 doi: 10.1016/j.phrs.2024.107364
|